Approval

• UBS announced on March 27, 2026, that its US subsidiary, UBS Bank USA, was approved by the Office of the Comptroller of the Currency for a national bank charter. • This approval expands UBS's US banking operations amid fintech sector growth. • The move positions UBS to compete more directly in the US digital banking landscape.

• The U.S. Senate passed the 21st Century ROAD to Housing Act on March 24, 2026, sending it back to the House to increase housing supply through reforms. • The legislation targets zoning and permitting barriers to boost construction amid ongoing housing shortages. • Passage marks a key step in addressing national housing crisis, potentially easing affordability for millions if enacted.

ACA requires firms to cover colonoscopies for over-45s but young people face hurdles to receive appropriate testsAs colon cancer rates are rising among people in their 20s and 30s, some adults in the US who are under 45 and experiencing worrying symptoms are struggling to get insurance coverage for colonoscopies, which can detect colon cancer.The Affordable Care Act (ACA) requires insurance companies to cover colonoscopies for people over 45 “because it’s been recommended by the US Preventive Services Task Force”, says Caitlin Murphy, a cancer epidemiologist and professor at the University of Chicago. The ACA requires preventive screenings, including pap smears, for example, to be completely covered. Continue reading...

• Johnson & Johnson has received FDA approval for a new psoriasis treatment pill, expanding therapeutic options for patients with the chronic skin condition. • The United States smoking rate has quietly reached a historical low, reflecting decades of public health efforts and tobacco control policies. • These developments represent significant milestones in pharmaceutical innovation and public health outcomes across different therapeutic areas.

• The FDA on March 13 expanded approval of GSK's Arexvy RSV vaccine to adults aged 18-49 at increased risk of lower respiratory tract disease. • Phase 3b trial data showed non-inferior immune response in younger adults compared to those 60+, targeting 21 million U.S. adults under 50 with conditions like diabetes or obesity. • RSV causes 17,000 hospitalizations, 277,000 emergency visits, and 2 million outpatient visits yearly in this group, highlighting need for broader protection amid rising cases.